Photo Credit: Courtesy of Dello Russo Laser Vision
For more than three decades, one surgeon has come to represent the premium end of American laser vision correction. Dr. Jeffrey Dello Russo leads Dello Russo Laser Vision, the family-owned practice that helped bring LASIK into mainstream American medicine and has remained one of the names patients trust for precision, discretion, and a track record measured in decades.
Long before LASIK became a household name, the Dello Russo family was helping shape the future of refractive surgery. The practice participated in early clinical research that contributed to FDA approval of LASIK in the United States, establishing authority in the field years before many competitors entered the market. That history continues to attract patients who evaluate their options before choosing a surgeon.
A Family Practice in a Category of Chains
Most laser vision centers in the United States are now owned by private investment groups or operate as franchise networks. Dello Russo Laser Vision has remained family-operated, with locations across New York, New Jersey, and Connecticut and a procedural history exceeding 200,000 surgeries. For patients who value continuity and long-term relationships, that consistency remains a defining characteristic.
Dr. Dello Russo trained within this legacy and built his career around it. The firm’s Chief Strategy Officer, Marshall Wade, describes the practice’s position clearly:
“We were at the forefront of laser vision correction during the original FDA trials and today are one of the largest practices by volume and experience.”
That experience matters. A surgeon involved in hundreds of thousands of refractive procedures develops judgment shaped by decades of pattern recognition across eye anatomies and patient needs.
Why Discerning Patients Choose Him
Refractive surgery is often marketed as a single procedure with a predictable outcome. In Dr. Dello Russo’s practice, treatment begins with determining which procedure best fits the patient. Some individuals are ideal LASIK candidates. Others are better suited for EVO ICL, a lens-based alternative offered to patients whose prescriptions or corneal characteristics make LASIK less suitable.
The emphasis is on matching the patient to the procedure rather than fitting everyone into the same solution.
That approach appeals to individuals whose careers depend on visual performance. Executives, athletes, performers, and on-camera professionals often arrive with expectations regarding vision quality. Consultations tend to focus on individual anatomy and long-term outcomes rather than a standardized sales process.
Where Current Technology Meets Surgical Experience
Dr. Dello Russo’s practice has consistently adopted advanced refractive technologies. The firm was among the first in the Northeast to introduce the Alcon WaveLight Plus, an AI-assisted LASIK platform that creates individualized treatment plans through detailed ray-tracing of each patient’s eye.
For an experienced surgeon, this technology serves as a refinement rather than a replacement for expertise. It supports personalized treatment planning where small details influence visual quality. Many patients seeking surgery today are not focused solely on achieving 20/20 vision. They are seeking visual performance that supports the demands of both professional and personal life.
A Reputation Earned, Not Advertised
What ultimately distinguishes Dr. Jeffrey Dello Russo is the way his reputation has been built through patient outcomes, referrals, and a family practice committed to longevity. In a field where many names rise and fall with marketing cycles, his has remained consistently recognized for more than thirty years. For patients who view their vision as essential to their work and lifestyle, that consistency remains one of the clearest signs of patient confidence.
Disclaimer: Written in partnership with APG.
